850
Helvetica Chimica Acta – Vol. 89 (2006)
1260s, 1151m, 1118m, 1097m (sh), 1055m, 1003m, 931w, 864m, 799m, 624m, 604m. 1H-NMR (CDCl3, 300
MHz): 3.98 (s, 2 Me); 7.14–7.18 (t, 3J=7.7, 1 H); 7.31–7.39 (m, 4 H); 7.44–7.47 (dd, 3J=7.08, 4J=1.7, 2
3
3
H); 7.79–7.81 (dd, J=6.75, 2 H); 7.83–7.86 (d, J=7.8, 2 H). EI-MS: 353 (100), 337 (10), 250 (8), 207
(10), 193 (10), 177 (30), 133 (15), 104 (15), 92 (13), 90 (13), 77 (100), 65 (26), 63 (30), 51 (66).
2-Phenyl-1H-benzimidazole. Benzene-1,2-diamine (2.03 g, 0.018 mol) and 3.31 g (0.027 mol) of
PhCOOH were mixed in 50 ml of H3PO4 (85%). The soln. was heated 2 h at 908 and then 4 h at 2008
under mechanical stirring. The mixture was poured into 200 ml of H2O and neutralized to pH 6 with
2M NaOH. The precipitate was filtered and suspended in 200 ml of an aq. soln. containing 10% of
Na2CO3. The suspension was heated to 608 for 1 h under magnetic stirring. The pink solid was then
dried under vacuum at 908. It was dissolved in MeOH and treated with charcoal for 1 h. The solid was
then recrystallized in MeOH: 2.44 g (0.0125 mol, 70%) of the product. M.p. >1908. 1H-NMR (CD
3ACHTREOUNG D,
300 MHz): 7.2–8.1 (m, 9 H). EI-MS :194 (100, M+), 97 (100), 90 (10), 77 (100), 63 (10).
1-Methyl-2-phenyl-1H-benzimidazole. 2-Phenyl-1H-benzimidazole (1.12 g, 5.7 mmol) was dissolved
in 50 ml of dry DMF (distilled over CaH2). The flask was then put into ice before 492 mg (ca. 10 mmol) of
NaH (50–60%) were added to the soln. The mixture was allowed to return to r.t. under magnetic stirring.
It stood for 1 h before 0.55 ml (8.8 mmol) of MeI was added. The soln. was kept under magnetic stirring at
r.t. for one night. During all the manipulations, the flask was kept under N2. The solvent was then evapo-
rated, the solid was dried and purified by CC (SiO2; CH2Cl2/MeOH 97:3). Yield: 60%. Soluble in MeOH,
EtOH, DMF, MeCN, acetone, CH2Cl2, CHCl3, and toluene; insoluble in Et2ACHTEROUNG , H2O, and hexane. M.p.
92–938. UV/VIS (DMF): 286 (15300). IR: 3060m, 2947m, 1943w, 1901w, 1777w, 1680w, 1610m, 1523m,
1466s, 1440s, 1380vs, 1327s, 1275m, 1250w, 1240m, 1177w, 1155m, 1126m, 1100m, 1076m, 1058m,
1020m, 1002m, 973w, 927m, 876w, 850w, 817m, 778s, 754vs, 700s, 679m, 540m, 484m. 1H-NMR (CD
3ACHTREOUNG D,
300 MHz): 3.88 (s, Me); 7.38–7.27 (m, 2 arom. H); 7.54–7.61 (m, 4 arom. H); 7.66–7.69 (m); 7.76–7.79
(m, 2 arom. H). EI-MS: 208 (75, M+), 207 (100), 129 (6), 104 (19), 90 (16), 77 (22), 63 (9), 51 (13).
2-(1H-Benzimidazolyl-2-yl)phenol. Benzene-1,2-diamine (4 g, 0.037 mol) and 5.5 g (0.04 mol) of sal-
icylic acid were dissolved in 50 ml of H3PO4 (85%). The salicylic acid sublimes below 1408; therefore, a
slight excess is needed. The soln. was heated 1 h at 1808 and 2 h at 2308. It was then allowed to cool and
poured into 200 ml of H2O. It was neutralized to pH 6 with 5M NaOH. The black precipitate was filtered
and suspended in 100 ml of an aq. soln. containing 40% Na2CO3. The mixture was heated at 608 for 1 h.
The solid was then treated with charcoal in MeOH and recrystallized from a mixture of EtOH and H2O.
Yield: 12%. M.p. >1808. IR: 3260m, 2918m, 1628w, 1588m, 1532m 1513s, 1486s, 1458s, 1434s, 1414m,
1395s, 1368m, 1317m, 1294m, 1276s, 1257s, 1223m, 1188m, 1157m, 1142m, 1129m, 1112m, 1081m,
1036w, 1003w, 960w, 904w, 839m, 820m, 798s, 738vs, 697m. 1H-NMR (CD
3ACHTREOUNG D, 300 MHz): 6.93–7.02
(m, 2 H); 7.22–7.27 (m, 2 H); 7.3–7.35 (m, 1 H); 7.57–7.69 (m, 2 H); 7.82–7.89 (dd, 1 H). EI-MS: 210
(100, M+), 182 (52), 156 (10), 143 (8), 129 (4), 105 (9), 91 (28), 68 (20), 65 (24), 63 (20), 51 (12).
1-Methoxy-2-(1-Methyl-1H-benzimidazol-2-yl)benzene. 2-(1H-Benzimidazol-2-yl)phenol (0.5 g, 2.38
mmol) was dissolved in 40 ml of dry DMF (distilled over CaH2). The flask was put into ice and 0.21 g (ca.
5 mmol) of NaH (50–60%) were added. The soln. was allowed to return to r.t. under magnetic stirring.
After 1 h, the soln. was again put into ice, and 0.74 g (5 mmol) of MeI was added. The mixture warmed up
to r.t. and left for a further 2 h under magnetic stirring. The product was purified by CC (SiO2; initially
100% of CH2Cl2 and then with CH2Cl2/MeOH 99.5:0.5). Yield: 58%. M.p. 98–1008. IR: 3381s, 3062s,
2945s, 2845s, 1647m, 1602s, 1577s, 1552m, 1520s, 1485s, 1457s, 1430s, 1380vs, 1324s, 1276s, 1252vs,
1235s, 1177s, 1149m, 1130m, 1120m, 1094s, 1053s, 1022vs, 1004m, 969m, 951m, 928m, 823m, 799m,
1
781s, 750vs. H-NMR (CDCl3, 300 MHz): 3.66 (s, MeN); 3.88 (s, MeO); 7.05–7.l (d, 1 H); 7.29–7.33
(m, 2 H); 7.39–7.42 (m, 1 H); 7.48–7.51 (m, 1 H); 7.57–7.6 (dd, 1 H); 7.81–7.84 (m, 1 H). EI-MS: 238
(95, M+), 237 (73), 209 (14), 208 (17), 207 (100), 77 (24), 51 (13).
2-(1-Methyl-1H-benzimidazol-2-yl)phenol. 1-Methoxy-2-(1-methyl-1H-benzimidazol-2-yl)benzene
(0.338 g, 1.4 mmol) was dissolved in 40 ml of dry CH2Cl2 (distilled over CaH2). The flask was put into
ice, and 7 ml (7 mmol) of a soln. of BBr3 1M in CH2Cl2 were added dropwise to the soln. The flask was
left, under magnetic stirring, until the ice melted and the H2O warmed to r.t. It was kept under magnetic
stirring over night. The excess of BBr3 was first hydrolyzed with MeOH (puriss.) and stirred for 10 min.
The solvent was then evaporated, and the solid was dried 1 h under vacuum. H2O (60 ml) was then
poured onto the solid, and the mixture was neutralized to pH 6 with 2M NaOH. The product was then